We can design or customize standard study protocols based on the characteristics of the drug and client needs, and conduct drug local toxicity tests under GLP-compliant conditions that meet the regulatory and technical requirements of ICH, NMPA, and the FDA, in order to support applications for clinical trials or marketing authorization.